Rikie M Scholtens1, Barbara C van Munster2, Marijn F van Kempen3, Sophia E J A de Rooij4. 1. Academic Medical Center, University of Amsterdam, Department of Internal Medicine, Geriatrics section, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. Electronic address: r.m.scholtens@amc.uva.nl. 2. Academic Medical Center, University of Amsterdam, Department of Internal Medicine, Geriatrics section, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; Gelre Hospitals, Department of Geriatrics, Albert Schweitzerlaan 31, 7334 DZ Apeldoorn, The Netherlands. 3. Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. 4. Academic Medical Center, University of Amsterdam, Department of Internal Medicine, Geriatrics section, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands; University Medical Center Groningen, University Centre for Geriatric Medicine, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
Abstract
OBJECTIVE: Melatonin plays a major role in maintaining circadian rhythm. Previous studies showed that its secretion pattern and levels could be disturbed in persons with dementia, psychiatric disorders, sleep disorders or with cancer. Also ageing is a factor that could alter melatonin levels, although previous research provides contradicting results. As melatonin supplementation is increasingly applied in older persons as sleep medication, it is important to know if melatonin levels decrease in healthy ageing and/or secretion patterns change. The objective of this study is to determine physiological levels and secretion patterns of melatonin in healthy older people. METHODS: We performed a systematic review and searched PubMed and Embase for studies published between January 1st 1980 and October 5th 2015 that measured melatonin in healthy persons aged ≥65years. RESULTS: Nineteen studies were retrieved. The number of participants ranged from 5 to 60 per study. Melatonin was mostly measured by radioimmunoassay (RIA) and the number of measurements per 24hours varied from 1 to 96. Sixteen studies showed a secretion pattern with a clear peak concentration, mostly at 0200h or 0300h. Maximum concentrations varied greatly from 11.2 to 91.3pgml(-1). Maximum melatonin level in studies with participants mean aged 65-70years was 49.3pgml(-1) and in studies with participants mean aged ≥75years 27.8pgml(-1), p-value <0.001. CONCLUSION: Total melatonin production in 24hours seems not to change in healthy ageing, but the maximal nocturnal peak concentration of melatonin might decline. It is important to take this into account when prescribing melatonin supplementation to older people.
OBJECTIVE:Melatonin plays a major role in maintaining circadian rhythm. Previous studies showed that its secretion pattern and levels could be disturbed in persons with dementia, psychiatric disorders, sleep disorders or with cancer. Also ageing is a factor that could alter melatonin levels, although previous research provides contradicting results. As melatonin supplementation is increasingly applied in older persons as sleep medication, it is important to know if melatonin levels decrease in healthy ageing and/or secretion patterns change. The objective of this study is to determine physiological levels and secretion patterns of melatonin in healthy older people. METHODS: We performed a systematic review and searched PubMed and Embase for studies published between January 1st 1980 and October 5th 2015 that measured melatonin in healthy persons aged ≥65years. RESULTS: Nineteen studies were retrieved. The number of participants ranged from 5 to 60 per study. Melatonin was mostly measured by radioimmunoassay (RIA) and the number of measurements per 24hours varied from 1 to 96. Sixteen studies showed a secretion pattern with a clear peak concentration, mostly at 0200h or 0300h. Maximum concentrations varied greatly from 11.2 to 91.3pgml(-1). Maximum melatonin level in studies with participants mean aged 65-70years was 49.3pgml(-1) and in studies with participants mean aged ≥75years 27.8pgml(-1), p-value <0.001. CONCLUSION: Total melatonin production in 24hours seems not to change in healthy ageing, but the maximal nocturnal peak concentration of melatonin might decline. It is important to take this into account when prescribing melatonin supplementation to older people.
Authors: Robert T Dauchy; David E Blask; Aaron E Hoffman; Shulin Xiang; John P Hanifin; Benjamin Warfield; George C Brainard; Murali Anbalagan; Lynell M Dupepe; Georgina L Dobek; Victoria P Belancio; Erin M Dauchy; Steven M Hill Journal: Comp Med Date: 2019-09-20 Impact factor: 0.982
Authors: Rikie M Scholtens; Sophia E J A de Rooij; Annelies E Vellekoop; Bart C Vrouenraets; Barbara C van Munster Journal: PLoS One Date: 2016-12-09 Impact factor: 3.240
Authors: José A Rubiño; Antoni Gamundí; Mourad Akaarir; Francesca Canellas; Rubén Rial; M Cristina Nicolau Journal: Front Neurosci Date: 2020-05-06 Impact factor: 4.677
Authors: Elena M Varoni; Rita Paroni; Jacopo Antognetti; Giovanni Lodi; Andrea Sardella; Antonio Carrassi; Marcello Iriti Journal: Molecules Date: 2018-09-27 Impact factor: 4.411
Authors: Pawel P Posadzki; Ram Bajpai; Bhone Myint Kyaw; Nicola J Roberts; Amnon Brzezinski; George I Christopoulos; Ushashree Divakar; Shweta Bajpai; Michael Soljak; Gerard Dunleavy; Krister Jarbrink; Ei Ei Khaing Nang; Chee Kiong Soh; Josip Car Journal: BMC Med Date: 2018-02-05 Impact factor: 8.775